293 related articles for article (PubMed ID: 14729970)
41. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
[TBL] [Abstract][Full Text] [Related]
42. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.
Shimabe M; Goyama S; Watanabe-Okochi N; Yoshimi A; Ichikawa M; Imai Y; Kurokawa M
Oncogene; 2009 Dec; 28(49):4364-74. PubMed ID: 19767769
[TBL] [Abstract][Full Text] [Related]
43. Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility.
Sang BC; Shi L; Dias P; Liu L; Wei J; Wang ZX; Monell CR; Behm F; Gruenwald S
Blood; 1997 Apr; 89(8):2909-14. PubMed ID: 9108411
[TBL] [Abstract][Full Text] [Related]
44. Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.
Chang CP; Jacobs Y; Nakamura T; Jenkins NA; Copeland NG; Cleary ML
Mol Cell Biol; 1997 Oct; 17(10):5679-87. PubMed ID: 9315626
[TBL] [Abstract][Full Text] [Related]
45. Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias.
LeBrun DP; Cleary ML
Oncogene; 1994 Jun; 9(6):1641-7. PubMed ID: 8183558
[TBL] [Abstract][Full Text] [Related]
46. Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.
Honda H; Inaba T; Suzuki T; Oda H; Ebihara Y; Tsuiji K; Nakahata T; Ishikawa T; Yazaki Y; Hirai H
Blood; 1999 May; 93(9):2780-90. PubMed ID: 10216071
[TBL] [Abstract][Full Text] [Related]
47. Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.
Smith KS; Rhee JW; Cleary ML
Mol Cell Biol; 2002 Nov; 22(21):7678-87. PubMed ID: 12370314
[TBL] [Abstract][Full Text] [Related]
48. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
[TBL] [Abstract][Full Text] [Related]
49. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
[TBL] [Abstract][Full Text] [Related]
50. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
[TBL] [Abstract][Full Text] [Related]
51. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia.
Van Dijk MA; Voorhoeve PM; Murre C
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6061-5. PubMed ID: 8327485
[TBL] [Abstract][Full Text] [Related]
52. GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.
Holmlund T; Lindberg MJ; Grander D; Wallberg AE
Leukemia; 2013 Mar; 27(3):578-85. PubMed ID: 23044487
[TBL] [Abstract][Full Text] [Related]
53. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients.
Jiménez-Morales S; Miranda-Peralta E; Saldaña-Alvarez Y; Perez-Vera P; Paredes-Aguilera R; Rivera-Luna R; Velázquez-Cruz R; Ramírez-Bello J; Carnevale A; Orozco L
Leuk Res; 2008 Oct; 32(10):1518-22. PubMed ID: 18455790
[TBL] [Abstract][Full Text] [Related]
54. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1.
Knoepfler PS; Bergstrom DA; Uetsuki T; Dac-Korytko I; Sun YH; Wright WE; Tapscott SJ; Kamps MP
Nucleic Acids Res; 1999 Sep; 27(18):3752-61. PubMed ID: 10471746
[TBL] [Abstract][Full Text] [Related]
55. E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.
Duque-Afonso J; Lin CH; Han K; Wei MC; Feng J; Kurzer JH; Schneidawind C; Wong SH; Bassik MC; Cleary ML
Cancer Res; 2016 Dec; 76(23):6937-6949. PubMed ID: 27758892
[TBL] [Abstract][Full Text] [Related]
56. Gradient of E2A activity in B-cell development.
Herblot S; Aplan PD; Hoang T
Mol Cell Biol; 2002 Feb; 22(3):886-900. PubMed ID: 11784864
[TBL] [Abstract][Full Text] [Related]
57. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
Wang GG; Pasillas MP; Kamps MP
Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
[TBL] [Abstract][Full Text] [Related]
58. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
59. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
60. The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver.
DiMartino JF; Selleri L; Traver D; Firpo MT; Rhee J; Warnke R; O'Gorman S; Weissman IL; Cleary ML
Blood; 2001 Aug; 98(3):618-26. PubMed ID: 11468159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]